ANI Pharmaceuticals's total assets for Q2 2025 were $1.34B, an increase of 3.91% from the previous quarter. ANIP total liabilities were $906.24M for the fiscal quarter, a 6.75% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.